Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
2017 · Nature Communications · 480 citations
https://doi.org/10.1038/s41467-017-01460-0
R
Rikke Andersen
Herlev Hospital(DK)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
91
Papers
3.3K
Citations
28
h-index
32
i10-index
Rikke Andersen is an academic researcher from Herlev Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers. The author has an h-index of 28, co-authored 78 publications.
ORCID: 0000-0002-3536-5523Papers by this author
worksClinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
2017 · Nature Communications · 165 citations
https://doi.org/10.1038/s41467-017-00786-z
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
2012 · Journal of Translational Medicine · 164 citations
https://doi.org/10.1186/1479-5876-10-169
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
2025 · Journal for ImmunoTherapy of Cancer · 1 citations
https://doi.org/10.1136/jitc-2024-010575
1547P Clinical outcomes of patients with acquired resistance to checkpoint inhibitors in melanoma, renal cell carcinoma and non-small cell lung cancer
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.2178
Lederes trivsel og arbejdsmiljø:Kvalitativ analyse af interviews med ledere i Region Syddanmark
2025 · VBN Forskningsportal (Aalborg Universitet) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat